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Abstract 20 
Endothelial progenitor cells (EPCs) are a vasculogenic subset of progenitors, which play a key 21 
role in maintenance of endothelial integrity. These cells are exercise-responsive, and thus 22 
exercise may play a key role in vascular repair and maintenance via mobilization of such cells. 23 
Blood flow restriction exercise, due to the augmentation of local tissue hypoxia, may promote 24 
exercise-induced EPC mobilization. Nine, healthy, young (18-30yrs) males participated in the 25 
study. Participants undertook 2 trials of single leg knee extensor (KE) exercise, at 60% of thigh 26 
occlusion pressure (4 sets at 30% maximal torque) (blood flow restriction; BFR) or non- blood 27 
flow restriction (non-BFR), in a fasted state. Blood was taken prior, immediately after, and 30 28 
minutes after exercise. Blood was used for the quantification of haematopoietic progenitor cells 29 
(HPCs: CD34+CD45dim), EPCs (CD34+VEGFR2+/CD34+CD45dimVEGFR2+) by flow 30 
cytometry. Our results show that unilateral KE exercise did not affect circulating HPC levels 31 
(p = 0.856), but did result in increases in both CD34+VEGFR2+ and CD34+CD45dimVEGFR2+ 32 
EPCs, but only in the non-BFR trial (CD34+VEGFR2+: 269 ± 42 cells·mL-1 to 573 ± 90 33 
cells·mL-1, pre- to immediately post-exercise, p = 0.008; CD34+CD45dimVEGFR2+: 129 ± 21 34 
cells·mL-1  to 313 ± 103 cells·mL-1, pre- to 30 min post-exercise,  p = 0.010). In conclusion, 35 
low load BFR exercise did not result in significant circulating changes in EPCs in the post-36 
exercise recovery period and may impair exercise-induced EPC mobilization compared to non-37 
BFR exercise. 38 
 39 
 40 
 41 
 42 
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1. Introduction 43 
Endothelial progenitor cells (EPCs) were first discovered in 1997 by Asahara et al. (1997). 44 
These peripheral blood mononuclear cells (PBMC) could form endothelial cell-like networks 45 
and differentiate into mature endothelial cell phenotypes in vitro. These cells are bone marrow-46 
derived and can be mobilized in response to vascular injury or an inflammatory stimulus 47 
(Asahara et al., 1999; Shintani et al., 2001). Since 1997, there have been a plethora of studies 48 
reporting their vasculogenic, angiogenic and vascular repair properties (Abd El Aziz et al., 49 
2015; Yu et al., 2016; Chilla et al., 2018; Kong et al., 2018). In vascular disease states and in 50 
advancing age, circulating EPC number and function are lower (Fadini et al., 2006; Thijssen et 51 
al., 2006; Xia et al., 2012; Liao et al., 2014). It is reported that these cells are independent 52 
predictors of endothelial function (Sibal et al., 2009; Bruyndonckx et al., 2014), and may also 53 
be predictors of cardiovascular mortality (Rigato et al., 2016). 54 
Exercise has been shown to improve endothelial function (Black et al., 2009), which is likely 55 
due to the regular elevations in shear stress (Tinken et al., 2010) that occurs due to elevated 56 
cardiac output and metabolic demand of the working muscle. Recently, acute bouts of exercise 57 
have been shown to mobilize EPCs from bone marrow and into the circulation (Van 58 
Craenenbroeck et al., 2008; Ross et al., 2014), which may contribute to endothelial growth and 59 
repair. However, in some populations, such as older individuals (Ross et al., 2018) and heart 60 
failure patients (Van Craenenbroeck et al., 2011), the acute exercise response is impaired.  61 
Blood flow restriction (BFR) exercise has been recently used to augment muscle hypertrophy 62 
(building muscle tissue) and strength whilst undertaking low-load resistance training (Abe et 63 
al., 2012). This is of interest to individuals who are unable to undertake higher-load training, 64 
such as injured athletes, older or diseased populations. Interestingly, BFR exercise may 65 
improve vascular function compared to non-restricted exercise (matched for workload) 66 
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(Horiuchi and Okita, 2012), which may make BFR exercise an option for individuals with 67 
vascular disease who cannot undertake moderate-to-high intensity exercise. One potential 68 
mechanism is the exercise-induced elevations in key angiogenic stimuli, such as vascular 69 
endothelial growth factor (VEGF), which is elevated in low-load BFR exercise compared to 70 
low-load exercise without BFR as a control (Larkin et al., 2012; Ferguson et al., 2018). This, 71 
in addition with other hypoxic stimuli, may stimulate the mobilization and recruitment of EPCs 72 
from the bone marrow, which can then act to stimulate vascular repair in areas of endothelial 73 
damage/dysfunction. Therefore we wanted to investigate the influence of BFR exercise on EPC 74 
mobilization in young, healthy men. It was hypothesized that BFR exercise would augment the 75 
exercise-induced mobilization of EPCs. 76 
 77 
2. Methods 78 
 79 
2.1 Ethical Approval 80 
This study was carried out in accordance with the recommendations of Edinburgh Napier 81 
University Research and Ethics Governance Committee. The study was ethically approved by 82 
Edinburgh Napier University Research and Ethics Governance Committee. All participants 83 
gave written informed consent in accordance with the Declaration of Helsinki.  84 
 85 
2.2 Participants 86 
Nine healthy adult males (age 18-30yrs) volunteered to take part in the study. Participants were 87 
physically active (took part in formal exercise training at least 2 x per week), non-obese 88 
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(BMI<30m·kg2), non-smokers, and not taking any medications. Participants were told to 89 
refrain from undertaking strenuous exercise for 2 days prior to the visits to the Human 90 
Performance Laboratory. Participant characteristics are provided in Table 1. 91 
 92 
2.3 Experimental Design 93 
In a repeated measures randomised design, participants performed fasted, unilateral, low-load, 94 
knee extension (KE) exercise (dominant leg) on an isokinetic dynamometer (Cybex Humac 95 
Norm, Computer Sports Medicine Inc, USA). Two experimental trials were undertaken, a low-96 
load KE exercise (1) with and (2) without BFR, with a minimum of one week apart.  97 
 98 
2.4 Assessment of Peak Torque 99 
One week prior to the first experimental trial, participants undertook a KE maximal torque test 100 
(1RM) on the isokinetic dynamometer after a 5 minute warm up on a bicycle ergometer (75W, 101 
60rpm). Participants initially performed 5 repetitions, through 90° range of motion at 60° per 102 
second concentrically at ~75% of maximal effort, followed by a short rest period before 103 
attempting a further 5 repetitions, with participants given the instruction to produce maximal 104 
efforts. 1RM was determined as the maximal voluntary torque produced throughout a 105 
controlled and full range of motion repetition. After the maximal torque assessment, 106 
participants were fitted with the pneumatic cuff placed on the dominant thigh, and performed 107 
5 repetitions to familiarise the participants with the BFR prior to the experimental trials. 108 
 109 
2.5 Experimental Trials 110 
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After a minimum of 7 days following the maximal torque assessment, participants returned to 111 
the Human Performance Laboratory in a fasted state, having refrained from strenuous exercise 112 
for 48 hours prior to the visit, and having refrained from caffeine and alcohol the night before 113 
the visit. Participants underwent a warm up consisting of a 5 minute cycle (Monark 824E, 114 
Monark Exercise AB, Sweden) at 75W at 60rpm, followed by 5 warm up KE repetitions at 115 
20% 1RM. The exercise trial consisted of 4 sets of unilateral knee extensions at 20% 1RM at 116 
a cadence of 1.5 seconds per contraction phase across 90° range of motion and at a speed of 117 
60° per second (1 set of 30 repetitions, followed by 3 sets of 15 repetitions) interspersed with 118 
30 second recovery periods, similar to previous work in this area (Drummond et al., 2008; 119 
Ferguson et al., 2018). Throughout the 4 sets, participants were fitted with a thigh occlusion 120 
cuff (Hokanson CC17 Thigh Cuff, Hokanson Inc, USA) at the most proximal end of their 121 
dominant leg, either inflated to 60% of their thigh occlusion pressure (BFR) or 5mmHg (non 122 
BFR). Thigh occlusion pressure was identified as the highest pressure at which arterial blood 123 
flow could not be detected by a vascular Doppler (BT-200 Vascular Doppler, Bistos Co. Ltd, 124 
Korea) on the posterior tibial artery. Occlusion pressure was maintained for the entirety of the 125 
exercise bout including inter-set rest periods. Blood samples were taken pre-, immediately 126 
post- and 30 minutes post-exercise by venepuncture (see 2.5 Blood Sampling and EPC 127 
Phenotyping).  128 
All participants undertook the exercise at the same time of day as their first experimental trial 129 
(0830-1000).  130 
 131 
2.5 Blood Sampling and Endothelial Progenitor Cell Phenotyping 132 
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Blood was taken from participants before, immediately post- and 30 minutes post-exercise bout 133 
by a trained phlebotomist using a 21-guage needle (BD Luer-Lok™, BD Biosciences, UK). 134 
Peripheral blood from the antecubital vein was drawn into 2 x 6mL vacutainers spray-coated 135 
with EDTA anti-coagulant (BD Biosciences, UK), with the first 3mL discarded to avoid 136 
contamination of circulating endothelial cells produced with the initial venepuncture. 137 
Differential leukocyte counts were determined using semi-automated haematology analyser 138 
(XS 1000i, Sysmex, UK).  139 
For flow cytometric quantification of EPCs, briefly, 200μL of whole blood was incubated with 140 
5μL of anti-CD34 FITC, 5μL anti-CD45 BV510 and 10μL anti-VEGFR2 PE (all BD 141 
Biosciences, UK) for 30 minutes away from light, followed by the addition of 2mL Lysis (BD 142 
Pharm Lyse™, BD Biosciences, UK) prior to flow cytometric analysis. EPCs were quantified 143 
using a BD FACS Celesta (BD Biosciences, UK) flow cytometer, equipped with a Violet laser 144 
(405nm), Blue laser (488nm) and a Yellow-Green laser (561nm). Compensation was 145 
performed prior to the study to correct for any spectral overlap, and controls (fluorescence 146 
minus 1) were used for each participants’ visit. Circulating EPC data was obtained using BD 147 
FACS Diva (BD Biosciences, UK). Firstly, CD45+ PBMCs were gated (Figure 1A), followed 148 
by identification of SSC-low and CD34+ events (Figure 1B), subsequent low expression of 149 
CD45 (CD45dim; Figure 1C) and VEGFR2+ events (Figure 1D) were identified. A minimum 150 
of 250,000 CD45+ PBMC events were collected per sample. Circulating concentrations of 151 
progenitor cells were obtained using a dual platform method, by multiplying the percentage 152 
values obtained from the flow cytometer by the corresponding leukocyte count as obtained 153 
from haematology analysis.  154 
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Changes in blood volume was accounted for by using known measures of haematocrit and 155 
haemoglobin obtained from automated haematology analysis (Sysmex, XS 1000i, UK) (Dill 156 
and Costill, 1974).  157 
 158 
2.6 Statistical analysis 159 
All data are presented as mean ± SEM unless otherwise stated. Two-way analyses of variance 160 
(ANOVA) with repeated measures were performed to investigate main effects of the exercise 161 
bout on circulating progenitor cells, and interaction of time (pre-, post-, 30 min post-exercise) 162 
x trial (BFR vs. non-BFR). When significant differences were detected, Bonferroni post-hoc 163 
tests were performed to determine location of the effect (pre, post- 1 hour post-exercise). Effect 164 
sizes are presented as Pearson’s r coefficient for ANOVA analyses, and Cohen’s d for paired 165 
analyses. Data was analysed using GraphPad Prism 8 for Windows (GraphPad Software Inc, 166 
USA). Significance alpha was set at p < 0.05. 167 
 168 
3. Results 169 
 170 
3.1 Unilateral Knee Extension Exercise- Performance 171 
There was no difference in torque produced during either BFR or non-BFR trial (75.89 ± 4.86N 172 
vs. 76.76 ± 5.96N, p = 0.911), which equated to 29.77 ± 1.12% vs. 31.44 ± 1.77% of maximal 173 
torque (p = 0.423).  174 
 175 
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3.2 Immunological Responses 176 
There was no main effect of the exercise bout on circulating neutrophils (F(2, 48) = 0.383, p = 177 
0.684, r = 0.09) or monocytes (F(2, 48) = 1.613, p = 0.210, r = 0.18) in the trials, but there was a 178 
main effect of exercise (pre- to post- and 30 minutes post-exercise) on circulating lymphocytes 179 
(F(2, 48) = 13.45, p < 0.001, r = 0.47). However, for all 3 subsets of circulating leukocytes, there 180 
was no time x trial interaction (p > 0.05). Leukocyte changes in response to BFR and non-BFR 181 
exercise are shown in Table 2. 182 
 183 
3.3 Endothelial Progenitor Cell Responses 184 
There was no main effect of the exercise bout on CD34+ progenitor cells (F(2, 48) = 0.1559, p = 185 
0.856, r = 0.06) or any interaction of time x trial (F(2, 48) = 0.2015, p = 0.818, r = 0.06). There 186 
was a main effect of time on CD34+VEGFR2+ EPCs (F(2, 48) = 4.175, p = 0.021, r = 0.28). 187 
However, as with CD34+ progenitors, there was no time x trial interaction (F(2, 48) = 1.199, p = 188 
0.310, r = 0.16). Likewise, there was a significant main effect of the exercise bout on 189 
CD34+CD45dimVEGFR2+ EPCs (F(2, 48) = 3.115, p = 0.049, r = 0.25), but no significant time x 190 
trial interaction was observed (F(2, 48) = 0.702, p = 0.501, r = 0.12). 191 
CD34+VEGFR2+ cells increased significantly from 269 ± 42 cells·mL-1 at rest to 573 ± 90 192 
cells·mL-1 (p = 0.008, d = 1.37) immediately post-non-BFR exercise, with a non-significant 193 
increase of 269 ± 42 cells·mL-1 to 373 ± 33 cells·mL-1 in the BFR trial (p = 0.352, d = 0.87). 194 
CD34+VEGFR2+ EPCs were still significantly elevated 30 minutes post-exercise compared to 195 
pre-exercise levels, in the non-BFR trial only (269 ± 42 cells·mL-1  to 564 ± 128 cells·mL-1, p 196 
= 0.010, d = 0.98). CD34+CD45dimVEGFR2+ EPCs only significantly increased from pre- to 197 
30 min post-exercise in the non-BFR trial (129 ± 21 cells·mL-1  to 313 ± 103 cells·mL-1, p = 198 
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0.010, d = 1.23), with no such statistical differences in the BFR trial (116 ± 19 cells·mL-1  to 199 
177 ± 35 cells·mL-1, p = 0.010, d = 0.68) (Figure 2). 200 
 201 
Discussion  202 
 203 
This is the first study to investigate the effect of an acute bout of BFR exercise on circulating 204 
progenitor cells. Our main finding of the study was that BFR exercise mitigated the increase in 205 
circulating CD34+VEGFR2+ and CD34+CD45dimVEGFR2+ EPCs shown in the non-BFR 206 
exercise trial. There was no statistical significant time x trial interaction, we found that only 207 
the non-BFR exercise resulted in a statistical significant increase in both CD34+VEGFR2+ and 208 
CD34+CD45dimVEGFR2+ cells in the circulation, both of which resulted in a large effect 209 
(Cohen’s d > 0.8). We did not observe any changes in either trial in total CD34+CD45dim 210 
progenitor cells, suggestive of a specific exercise responsiveness of EPCs. We hypothesized 211 
that the BFR trial would augment the circulating EPC response to exercise, potentially due to 212 
elevation in local and systemic hypoxic and angiogenic stimuli that have been shown with acute 213 
bouts of BFR exercise (Larkin et al., 2012; Ferguson et al., 2018).  214 
Our previous work and others have shown that exercise can stimulate the mobilization of EPCs 215 
from the bone marrow of healthy young and older adults (Van Craenenbroeck et al., 2008; Ross 216 
et al., 2014; Ross et al., 2018). These increases in EPCs are observed concomitantly with 217 
elevations in plasma VEGF levels (Adams et al., 2004; Möbius-Winkler et al., 2009; Ross et 218 
al., 2014; Ross et al., 2018). Interestingly, despite elevations in VEGF mRNA, the resulting 219 
plasma VEGF concentrations did not differ between BFR and non-BFR trials in a previous 220 
BFR study (Larkin et al., 2012). Work by Ferguson et al. (2018) observed that VEGF gene 221 
expression in skeletal muscle increased in BFR exercise more so than non-BFR exercise after 222 
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2 and 4 hours. It is possible that hypoxic stimulus created by the BFR exercise, may result in 223 
sustained elevation in VEGF gene expression, which may result in increased skeletal muscle 224 
VEGF protein content and subsequent elevations in VEGF released into interstitial space and 225 
plasma after 4 hours. Our study focused on the initial circulating EPC response to the exercise 226 
bout, and found that BFR exercise appears to blunt the EPC mobilization immediately post-227 
exercise, and in the short term recovery period. However, there was a moderate-to-large effect 228 
for EPC mobilization post-BFR exercise (Cohen’s d between 0.67 and 0.87), however this was 229 
still a lower effect than observed for non-BFR exercise.  Future studies should employ further 230 
time points for analysis of EPC levels due to the possibility of any delayed VEGF release 231 
having a direct impact on EPC mobilization from the bone marrow. 232 
 233 
Participants in the current study undertook a single leg KE exercise (of the dominant leg). 234 
Previous studies have employed BFR exercise in a bilateral exercise trial (Ferguson et al., 235 
2018), or at a higher exercise intensity than our own (Larkin et al., 2012). We decided on a 236 
unilateral exercise trial and ~30% of maximal torque from pilot testing for participants being 237 
able to withstand the exercise trial, however, we know that exercise intensity plays an important 238 
role in progenitor cell responses to exercise (Laufs et al., 2005), and likely that more muscle 239 
mass involved in exercise may stimulate a greater systemic response. Therefore we recommend 240 
that further studies are employed to ascertain role of exercise intensity, as well as occlusion 241 
pressure, on EPC kinetics in individuals to fully explore this area of study. 242 
 243 
In addition to progenitor cell data, we also were able to quantify immunological response to 244 
the exercise trials. Either trial failed to stimulate significant changes in both neutrophils or 245 
monocytes. However, there was an effect of exercise on lymphocytes, with a significant 246 
redeployment of cells into the peripheral blood compartment, but there was no exercise x trial 247 
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interaction. Behringer et al. (2018) observed significant elevations in absolute neutrophil count 248 
after 4 sets of BFR exercise (repetitions at 75% 1RM). Immunological responses to exercise 249 
are highly intensity-dependent (Rowbottom and Green, 2000), and therefore the difference in 250 
intensity between our 2 studies are likely to be the reason for the differences in our findings. 251 
However, our BFR trial (4 sets at ~30% maximum torque) resulted in minimal immunological 252 
changes, and therefore may not perturb our immune system to the same extent as high intensity 253 
BFR exercise, thus making it an acceptable exercise mode for at-risk populations. However, 254 
more study is needed to investigate the influence of such bouts of exercise on specific immune 255 
cell subsets, such as T-cells, B-cells, NK-cells and pro-inflammatory monocytes. 256 
 257 
Limitations 258 
Our study has several limitations which must be appreciated. Firstly, our timescale of obtaining 259 
blood samples was limited, from pre-exercise to 30 minutes post-exercise. We observe a 260 
delayed angiogenic gene expression in response to BFR exercise, and thus, EPC response may 261 
also be delayed, on the basis that VEGF may stimulate exercise-induced EPC mobilization. In 262 
addition, our unilateral exercise protocol may not have been a sufficient stimulus for EPC 263 
mobilization. Despite this, we did observe a significant effect of low-intensity (~30% maximal 264 
torque) unilateral KE exercise on EPCs in the non-restricted trial, suggestive of other factors 265 
at play other than VEGF or other angiogenic signaling proteins. 266 
 267 
Our sample size (n=9), was less than was targeted (n>10 for power >95%) according to 268 
G*power calculations. However, we achieved 92% power with the n=9, and as such we are 269 
confident in our analyses of the data provided, which include larger effect sizes for changes in 270 
EPCs from pre-to-post-exercise in the non-BFR trial (Cohen’s d between 0.98 and 1.37) than 271 
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the BFR trial (Cohen’s d between 0.67 and 0.87), which failed to statistically alter the levels of 272 
EPCs in peripheral blood of the participants. 273 
 274 
Conclusion 275 
In summary, this is the first study to show that BFR exercise did not augment EPC response to 276 
exercise, and in fact blunted the EPC response to low load unilateral KE exercise in young, 277 
healthy males.  278 
 279 
Conflict of Interest 280 
The authors declare that the research was conducted in the absence of any commercial or 281 
financial relationships that could be construed as a potential conflict of interest. 282 
Author Contributions 283 
MR, RM, AP, CW, GFJ designed the study. MR, RM, AP, CW undertook data collection. MR, 284 
RM analysed the data. MR, GFJ wrote the manuscript. MR, RM, AP, CW, GFJ reviewed the 285 
data and the manuscript. All authors read and approved of the manuscript. 286 
 287 
Funding 288 
MR and this project was funded by Edinburgh Napier University’s Research Excellence Grant 289 
2017. 290 
 291 
Acknowledgments 292 
14 
 
The authors would like to acknowledge the assistance of Mr. Russell Wilson and Mr. Neil 293 
Guthrie in assistance and training in the use of the isokinetic dynamometer for the study. 294 
 295 
 296 
 297 
 298 
 299 
 300 
 301 
 302 
 303 
 304 
 305 
 306 
 307 
 308 
 309 
 310 
15 
 
References 311 
 312 
Abd El Aziz, M.T., Abd El Nabi, E.A., Abd El Hamid, M., Sabry, D., Atta, H.M., Rahed, 313 
L.A., et al. (2015). Endothelial progenitor cells regenerate infracted myocardium with 314 
neovascularisation development. J Adv Res 6(2), 133-144. doi: 10.1016/j.jare.2013.12.006. 315 
Abe, T., Loenneke, J.P., Fahs, C.A., Rossow, L.M., Thiebaud, R.S., and Bemben, M.G. 316 
(2012). Exercise intensity and muscle hypertrophy in blood flow-restricted limbs and non-317 
restricted muscles: a brief review. Clin Physiol Funct Imaging 32(4), 247-252. doi: 318 
10.1111/j.1475-097X.2012.01126.x. 319 
Adams, V., Lenk, K., Linke, A., Lenz, D., Erbs, S., Sandri, M., et al. (2004). Increase of 320 
circulating endothelial progenitor cells in patients with coronary artery disease after exercise-321 
induced ischemia. Arterioscler Thromb Vasc Biol 24(4), 684-690. doi: 322 
10.1161/01.ATV.0000124104.23702.a0. 323 
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., et al. (1999). Bone 324 
marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in 325 
physiological and pathological neovascularization. Circ Res 85(3), 221-228. 326 
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., et al. (1997). 327 
Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302), 964-328 
967. doi: 10.1126/science.275.5302.964. 329 
Behringer, M., Heinke, L., Leyendecker, J., and Mester, J. (2018). Effects of blood flow 330 
restriction during moderate-intensity eccentric knee extensions. The Journal of Physiological 331 
Sciences 68(5), 589-599. doi: 10.1007/s12576-017-0568-2. 332 
Black, M.A., Cable, N.T., Thijssen, D.H., and Green, D.J. (2009). Impact of age, sex, and 333 
exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol 297(3), 334 
H1109-1116. doi: 10.1152/ajpheart.00226.2009. 335 
Bruyndonckx, L., Hoymans, V.Y., Frederix, G., De Guchtenaere, A., Franckx, H., Vissers, 336 
D.K., et al. (2014). Endothelial progenitor cells and endothelial microparticles are 337 
independent predictors of endothelial function. J Pediatr 165(2), 300-305. doi: 338 
10.1016/j.jpeds.2014.04.015. 339 
16 
 
Chilla, A., Margheri, F., Biagioni, A., Del Rosso, M., Fibbi, G., and Laurenzana, A. (2018). 340 
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: 341 
the amoeboid angiogenesis. J Exp Clin Cancer Res 37(1), 74. doi: 10.1186/s13046-018-0742-342 
2. 343 
Dill, D.B., and Costill, D.L. (1974). Calculation of percentage changes in volumes of blood, 344 
plasma, and red cells in dehydration. J Appl Physiol 37(2), 247-248. doi: 345 
10.1152/jappl.1974.37.2.247. 346 
Drummond, M., Fujita, S., Takashi, A., Dreyer, H., Volpi, E., and Rasmussen, B. (2008). 347 
Human Muscle Gene Expression following Resistance Exercise and Blood Flow Restriction. 348 
Medicine & Science in Sports & Exercise 40(4), 691-698 doi: 349 
10.1249/MSS.0b013e318160ff84. 350 
Fadini, G.P., Coracina, A., Baesso, I., Agostini, C., Tiengo, A., Avogaro, A., et al. (2006). 351 
Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical 352 
atherosclerosis in a middle-aged general population. Stroke 37(9), 2277-2282. doi: 353 
10.1161/01.str.0000236064.19293.79. 354 
Ferguson, R.A., Hunt, J.E.A., Lewis, M.P., Martin, N.R.W., Player, D.J., Stangier, C., et al. 355 
(2018). The acute angiogenic signalling response to low-load resistance exercise with blood 356 
flow restriction. European Journal of Sport Science, 1-10. doi: 357 
10.1080/17461391.2017.1422281. 358 
Horiuchi, M., and Okita, K. (2012). Blood Flow Restricted Exercise and Vascular Function. 359 
International Journal of Vascular Medicine 2012, 17. doi: 10.1155/2012/543218. 360 
Kong, Z., Hong, Y., Zhu, J., Cheng, X., and Liu, Y. (2018). Endothelial progenitor cells 361 
improve functional recovery in focal cerebral ischemia of rat by promoting angiogenesis via 362 
VEGF. Journal of Clinical Neuroscience. doi: 10.1016/j.jocn.2018.07.011. 363 
Larkin, K.A., Macneil, R.G., Dirain, M., Sandesara, B., Manini, T.M., and Buford, T.W. 364 
(2012). Blood flow restriction enhances post-resistance exercise angiogenic gene expression. 365 
Med Sci Sports Exerc 44(11), 2077-2083. doi: 10.1249/MSS.0b013e3182625928. 366 
Laufs, U., Urhausen, A., Werner, N., Scharhag, J., Heitz, A., Kissner, G., et al. (2005). 367 
Running exercise of different duration and intensity: effect on endothelial progenitor cells in 368 
17 
 
healthy subjects. Eur J Cardio Prev Rehab 12(4), 407-414. doi: 369 
10.1097/01.hjr.0000174823.87269.2e. 370 
Liao, Y.-F., Feng, Y., Chen, L.-L., Zeng, T.-S., Yu, F., and Hu, L.-J. (2014). Coronary heart 371 
disease risk equivalence in diabetes and arterial diseases characterized by endothelial 372 
function and endothelial progenitor cell. J Diabetes Complications 28(2), 214-218. doi: 373 
10.1016/j.jdiacomp.2013.09.009. 374 
Möbius-Winkler, S., Hilberg, T., Menzel, K., Golla, E., Burman, A., Schuler, G., et al. 375 
(2009). Time-dependent mobilization of circulating progenitor cells during strenuous exercise 376 
in healthy individuals. J Appl Physiol 107(6), 1943-1950. doi: 377 
10.1152/japplphysiol.00532.2009. 378 
Rigato, M., Avogaro, A., and Fadini, G.P. (2016). Levels of Circulating Progenitor Cells, 379 
Cardiovascular Outcomes and Death. Circulation Research 118(12), 1930-1939. doi: 380 
doi:10.1161/CIRCRESAHA.116.308366. 381 
Ross, M.D., Malone, E.M., Simpson, R., Cranston, I., Ingram, L., Wright, G.P., et al. (2018). 382 
Lower resting and exercise-induced circulating angiogenic progenitors and angiogenic T cells 383 
in older men. Am J Physiol Heart Circ Physiol 314(3), H392-H402. doi: 384 
10.1152/ajpheart.00592.2017. 385 
Ross, M.D., Wekesa, A.L., Phelan, J.P., and Harrison, M. (2014). Resistance exercise 386 
increases endothelial progenitor cells and angiogenic factors. Med Sci Sports Exerc 46(1), 16-387 
23. doi: 10.1249/MSS.0b013e3182a142da. 388 
Rowbottom, D., and Green, K. (2000). Acute exercise effects on the immune system. 389 
Medicine & Science in Sports & Exercise 32(7), S396-S405. 390 
Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A., et al. (2001). 391 
Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction. 392 
Circulation 103(23), 2776-2779. doi: 10.1161/hc2301.092122. 393 
Sibal, L., Aldibbiat, A., Agarwal, S., Mitchell, G., Oates, C., Razvi, S., et al. (2009). 394 
Circulating endothelial progenitor cells, endothelial function, carotid intima–media thickness 395 
and circulating markers of endothelial dysfunction in people with type 1 diabetes without 396 
18 
 
macrovascular disease or microalbuminuria. Diabetologia 52(8), 1464-1473. doi: 397 
10.1007/s00125-009-1401-0  398 
Thijssen, D.H., Vos, J.B., Verseyden, C., van Zonneveld, A.J., Smits, P., Sweep, F.C., et al. 399 
(2006). Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of 400 
aging and training. Aging Cell 5(6), 495-503. doi: 10.1111/j.1474-9726.2006.00242.x. 401 
Tinken, T.M., Thijssen, D.H.J., Hopkins, N., Dawson, E.A., Cable, N.T., and Green, D.J. 402 
(2010). Shear stress mediates endothelial adaptations to exercise training in humans. 403 
Hypertension 55(2), 312-318. doi: 10.1161/hypertensionaha.109.146282. 404 
Van Craenenbroeck, E., Bruyndonckx, L., Van Berckelaer, C., Hoymans, V., Vrints, C., and 405 
Conraads, V. (2011). The effect of acute exercise on endothelial progenitor cells is attenuated 406 
in chronic heart failure. Eur J Appl Physiol 111(9), 2375-2379. doi: 10.1007/s00421-011-407 
1843-1. 408 
Van Craenenbroeck, E.M., Vrints, C.J., Haine, S.E., Vermeulen, K., Goovaerts, I., Van 409 
Tendeloo, V.F., et al. (2008). A maximal exercise bout increases the number of circulating 410 
CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile. J 411 
Appl Physiol 104(4), 1006-1013. doi: 10.1152/japplphysiol.01210.2007. 412 
Xia, W.H., Yang, Z., Xu, S.Y., Chen, L., Zhang, X.Y., Li, J., et al. (2012). Age-related 413 
decline in reendothelialization capacity of human endothelial progenitor cells is restored by 414 
shear stress. Hypertension 59(6), 1225-1231. doi: 415 
10.1161/HYPERTENSIONAHA.111.179820. 416 
Yu, J.W., Deng, Y.P., Han, X., Ren, G.F., Cai, J., and Jiang, G.J. (2016). Metformin 417 
improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS 418 
pathway in diabetic mice. Cardiovasc Diabetol 15(1), 88. doi: 10.1186/s12933-016-0408-3. 419 
 420 
 421 
 422 
 423 
19 
 
Tables and Figures 424 
 425 
Table 1. Participant Characteristics (n=9) 426 
Characteristics  
Age (years) 21 ± 1 
Body Mass Index (m·kg2) 25.77 ± 1.10 
Systolic Blood Pressure (mmHg) 131 ± 2 
Diastolic Blood Pressure (mmHg) 78 ± 2 
Knee Extensor Maximal Torque (N) 255 ± 16 
30% Maximal Torque (N) 75 ± 5 
Values shown are mean ± SEM. 427 
 428 
 429 
 430 
 431 
 432 
 433 
 434 
 435 
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Table 2. Circulating Leukocyte Changes in Response to Blood Flow Restricted (BFR) and 436 
non- Restricted (non-BFR) Exercise (n=9). 437 
  Pre Immediately 
Post- 
30 Min 
Post- 
Main Effect of 
Exercise 
Time x Trial 
Interaction 
Neutrophils 
(cells x 109·L-1) 
BFR 3.95 ± 0.44 4.47 ± 0.62 4.37 ± 0.59 
F(2, 48) = 0.383, 
p = 0.684 
F(2, 48) = 0.137, 
p = 0.872 
Non-BFR 3.38 ± 0.51 3.46 ± 0.54 3.93 ± 0.63 
Monocytes 
(cells x 109·L-1) 
BFR 0.56 ± 0.06 0.69 ± 0.08 0.56 ± 0.04 
F(2, 48) = 1.613, 
p = 0.210 
F(2, 48) = 0.515, 
p = 0.601 
Non-BFR 0.53 ± 0.04 0.57 ± 0.05 0.53 ± 0.05 
Lymphocytes 
(cells x 109·L-1) 
BFR 1.83 ± 0.18 2.31 ± 0.15 1.54 ± 0.12 
F(2, 48) = 13.450, 
p < 0.001* 
F(2, 48) = 0.981, 
p = 0.382 
Non-BFR 1.95 ± 0.09 2.31 ± 0.15 1.51 ± 0.05 
Values shown are mean ± SEM, *p < 0.001 438 
 439 
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 446 
Figure 1. Representative flow cytometry density and dot plots to quantify endothelial 447 
progenitor cells (EPCs). 1A- identification of CD45+ PBMCs, 1B- CD34+ gating, 1C- CD45dim 448 
expression on CD34+ progenitors, 1D- co-expression of VEGFR2. 449 
 450 
 451 
 452 
 453 
 454 
 455 
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 456 
Figure 2. Circulating CD34+CD45dim, CD34+VEGFR2+ EPCs, and CD34+CD45dimVEGFR2+ 457 
EPCs in response to blood flow restricted (BFR) and non-restricted (non-BFR) exercise (n=9). 458 
Values shown are mean ± SEM, * p <0.05 vs. pre-exercise non-BFR only. 459 
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